BIOS: BioPlus Acquisition Corp. - Summary | Jitta

BioPlus Acquisition Corp.

NASDAQ:BIOS

Price
$10.19
Loss Chance
58.1%
n/aJITTA SCORE
100.00%Over Jitta Line
Jitta Ranking
Sorry, the data is not yet available for this stock.
HISTORICAL JITTA SCORE
Sorry, the data is not yet available for this stock.
Jitta Factors
Growth Opportunity (2)
Recent Business Performance (17)
Financial Strength (9)
Return to Shareholders (0)
Competitive Advantage (1)
Jitta Signs
SG&A to SalesDecreasing Every Year
Cash Conversion CycleLess than 30 days
Recent IPOLess than 3 years
SG&A to SalesIncreasing Every Year
Key Stats
Jitta Score
Jitta Line
n/a
100.00%
0.79
> 1,000%
0.79
> 1,000%
4.41
53.66%
3.32
38.04%
2.67
16.43%
COMPANY DESCRIPTION
BioPlus Acquisition Corp. does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or other similar business combination with one or more businesses in the life sciences industry. The company was incorporated in 2021 and is based in New York, New York.